-
![Covishield Vaccine, AstraZeneca's Acknowledgment of Rare Side Effects]()
With its AZD1222 Covid-19 vaccine, which is marketed as Covishield in India, AstraZeneca has disclosed a rare but severe side effect
With its AZD1222 Covid-19 vaccine, which is marketed as Covishield in India, AstraZeneca has disclosed a rare but severe side effect
